Nivolumab: tested on its own
215 studies: no other medicine in its arm. Page 3 of 3. Open to participants first (28), then studies with results posted, then the rest; newest registration first within each.
- Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent Renal Cell Carcinoma (RCC)WithdrawnNCT02962804Phase 2Report a problem
- Study in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease ControlTerminatedNCT02959554Phase 2Report a problem
- Nivolumab Plus Radiotherapy in Advanced MelanomaCompletedNCT02799901Phase 2Report a problem
- SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or SpineCompletedNCT02716948Phase 1Report a problem
- Immune Modulation Study in Patients With Metastatic Melanoma Treated With Anti-PD1 Monoclonal AntibodiesCompletedNCT02626065Phase 4Report a problem
- Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)Active, not recruitingNCT02595944Phase 3Report a problem
- Nivolumab in Treating Patients With High-Risk Kidney Cancer Before SurgeryTerminatedNCT02595918Phase 1Report a problem
- ONO-4538 Study in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT02582125Phase 2Report a problem
- Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell CarcinomaCompletedNCT02575222Phase 1Report a problem
- Neoadjuvant Nivolumab in GlioblastomaCompletedNCT02550249Phase 2Report a problem
- Nivolumab in Patients With Recurrent Malignant MesotheliomaCompletedNCT02497508Phase 2Report a problem
- A Study of Anti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR)TerminatedNCT02446860Phase 2Report a problem
- Study of ONO-4538 in Unresectable Advanced or Recurrent Gastric CancerCompletedNCT02267343Phase 3Report a problem
- ONO-4538 Phase I Study in Patients With Solid TumorCompletedNCT02261298Phase 1Report a problem
- Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)Active, not recruitingNCT02194738Not applicableReport a problem